Maynard Um
-
-
-
-
-
-
-
Artisan Partners calls for Novartis board changes amid trial, acquisition failures
-
-
-
-
-
-
-
Novartis (NVS) call put ratio 1.6 calls 1 put into share price lower before the bell
-
-
-
-
-
-
-
Novartis wins EU approval for SMA gene therapy in older patients
-
-
-
-
-
-
-
Novartis reports kidney function benefits for IgAN drug in phase III trial
-
-
-
-
-
-
-
Novartis completes seventh US facility plan with North Carolina site
-
-
-
-
-
-
-
Novartis taps debt markets to fund $12 billion Avidity acquisition
-
-
-
-
-
-
-
Novartis (NVS) PT Raised to $180 at TD Cowen
-
461,980 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


